Investor Presentation First Nine Months of 2022

77 Investor presentation First nine months of 2022 Rare disease Rare disease background Rare disease innovation 23 78 81 novo nordisk ® SIERRA CLARK Sierra lives with Glanzmann-Thrombasthenia Canada

View entire presentation